Source: Infinity Stone Ventures Corp.
  • Infinity Stone (GEMS) has announced a non-brokered private placement for gross proceeds of up to $450,000
  • The company will issue up to 3,000,000 units for $0.15 per unit
  • Net proceeds will be used to fund marketing, software development and other general working capital
  • Infinity Stone is a technology company developing and delivering SaaS solutions for the public and private sectors
  • Infinity Stone Ventures Corp. (GEMS) opened trading at C$0.19

Infinity Stone (GEMS) has announced a non-brokered private placement for gross proceeds of up to $450,000.

The company will issue up to 3,000,000 units for $0.15 per unit. Each unit will include one share and one-half of one share purchase warrant. Each warrant will entitle the holder to acquire one additional share.

Net proceeds will fund marketing, software development and other general working capital.

Securities issued will be subject to a standard four-month hold period.

Infinity Stone is a technology company developing and delivering SaaS solutions for the public and private sectors. It integrates data collection and management (Smart Health RM), communications (Smart Connect), advertising (Engagency), and IoT devices (Smart Check).

Infinity Stone Ventures Corp. (GEMS) opened trading at C$0.19.

More From The Market Online

Westinghouse Electric files for US IPO

Westinghouse Electric Company, jointly owned by Cameco and Brookfield Renewable Partners, confidentially filed for a US IPO.

The 5-Minute Investor Podcast, Ep. 72: The next AI gold rush is copper

Check out ep. 72 of The 5-Minute Investor Podcast, with analysis on copper stocks Freeport-McMoRan and Capstone Copper.

Buzz on the Bullboards: Contracts, cashflows, and delistings

Uncertainty around Iran has weighed on sentiment, reminding investors that even strong stories can be overshadowed by geopolitical risk.

EU authorizes new COVID vaccine from Pfizer and BioNTech

The EU grants marketing authorization to Pfizer and BioNTech's COVID-19 vaccine targeting the new XFG variant.